All posts

NBLY stock spikes on revised buyout

If it wasn’t a trend before, surely it is now.

Another Canadian tech has been snatched up by a private equity firm. This time, it’s Neighbourly Pharmacy (Neighbourly Pharmacy Stock Quote, Chart, News, Analysts, Financials TSX:NBLY), completing a deal that was announced last fall, selling to Toronto-based Persistence Capital Partners, which was the largest shareholder of the firm, which went public in 2021.

The deal, which values NBLY at $18.50, is two bucks shy of the original buyout price, but had unanimous approval from the company’s board. According to a report in the Globe and Mail, Persistence Capital reduced the buyout price due to difficult market conditions.

“We are pleased that the Transaction Committee has unanimously agreed to support this enhanced offer, which provides a fair and attractive return to Neighbourly’s public shareholders,” said Stuart M. Elman, Managing Partner of PCP. “We are confident that this transaction will enable Neighbourly to accelerate its growth and achieve its strategic vision to advance the role that independent pharmacies can play across Canada, creating value for its customers, patients, employees, and partners.”

Toronto-based Neighbourly owns Canada’s largest network of independent pharmacies.

At press time, shares of NBLY were up 15.7 per cent to $18.22.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: nbly
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Uber stock a buy? (May, 2024)

Following the release of the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on… [Read More]

2 days ago

Trulieve scores price target raise at Echelon

Following the company's most recent results, Echelon Capital Markets analyst Andrew Semple has raised his price target on Trulieve Cannabis… [Read More]

2 days ago

Is Green Thumb Industries a buy? (May, 2024)

Its first quarter numbers are in the books and Beacon Securities analyst Russell Stanley is still bullish on Green Thumb… [Read More]

3 days ago

Is TKO stock a buy?

Following the company's first quarter results, Roth MKM analyst Eric Handler has maintained his "Buy" rating on TKO Group (TKO… [Read More]

3 days ago

Is WELL Health stock a buy? (May, 2024)

Following the company's first quarter results, Eight Capital analyst Christian Sgro thinks there is a lot of money to be… [Read More]

3 days ago

“You Never Get Fired for Buying Shopify”

Its first quarter results are in the books and ATB Capital Markets analyst Martin Toner has become bullish on Shopify… [Read More]

3 days ago